Acutus Medical, Inc. AFIB OTC · Healthcare · United States
$0.00 +0.00% +$0.00
Summary
29 / 100 · Bulios Score
What speaks for it
None of the indicators we track stands out on the positive side.
What to watch
- The company made a loss over the last 12 months.
- Operating profit does not even cover the interest on its debt.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 5.3% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $9.55M.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 1
- Hold 4
- Sell 1
Today's price within the analysts' price targets
The average target of $1.5 is 1,499,900% above today's price. 17% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2024By product
- Disposables 97%
- Product and Service, Other 2.6%
By region
- UNITED STATES 53%
- Non-US 47%
Disposables brings in 97% of revenue.
Segments in detail